Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tg Therapeuticscmn (TGTX)

Tg Therapeuticscmn (TGTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 778,505
  • Shares Outstanding, K 144,435
  • Annual Sales, $ 6,690 K
  • Annual Income, $ -348,100 K
  • 60-Month Beta 2.25
  • Price/Sales 130.42
  • Price/Cash Flow N/A
  • Price/Book 5.12
Trade TGTX with:

Options Overview Details

View History
  • Implied Volatility 143.34% ( -2.23%)
  • Historical Volatility 116.61%
  • IV Percentile 97%
  • IV Rank 87.38%
  • IV High 156.88% on 04/13/22
  • IV Low 49.54% on 06/21/21
  • Put/Call Vol Ratio 0.11
  • Today's Volume 804
  • Volume Avg (30-Day) 1,641
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 132,640
  • Open Int (30-Day) 168,025

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.44
  • Number of Estimates 4
  • High Estimate -0.38
  • Low Estimate -0.55
  • Prior Year -0.59
  • Growth Rate Est. (year over year) +25.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.81 +13.10%
on 05/20/22
7.93 -31.44%
on 05/04/22
-1.69 (-23.70%)
since 04/22/22
3-Month
4.81 +13.10%
on 05/20/22
10.87 -49.95%
on 04/05/22
-3.99 (-42.31%)
since 02/23/22
52-Week
4.81 +13.10%
on 05/20/22
41.00 -86.73%
on 07/02/21
-27.76 (-83.61%)
since 05/21/21

Most Recent Stories

More News
TG Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

Presentation available for on demand download beginning Tuesday May 24, 2022 at 7:00 AM ET...

TGTX : 5.44 (+0.93%)
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Lags Revenue Estimates

Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of 5.95% and 57.49%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

AGIO : 21.09 (-0.05%)
TGTX : 5.44 (+0.93%)
Zimmer Biomet (ZBH) Q1 Earnings and Revenues Surpass Estimates

Zimmer (ZBH) delivered earnings and revenue surprises of 15% and 4.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ZBH : 120.83 (+2.74%)
TGTX : 5.44 (+0.93%)
Will TG Therapeutics (TGTX) Report Negative Q1 Earnings? What You Should Know

TG Therapeutics (TGTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TGTX : 5.44 (+0.93%)
TG Therapeutics to Participate in the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference

Fireside chat scheduled for Thursday, April 28, 2022 at 12:30 PM ET...

TGTX : 5.44 (+0.93%)
Interesting TGTX Put And Call Options For June 17th

Investors in TG Therapeutics Inc saw new options begin trading this week, for the June 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TGTX options chain...

TGTX : 5.44 (+0.93%)
TG Therapeutics (TGTX) Withdraws FDA Submission, Stock Down

TG Therapeutics (TGTX) voluntarily withdraws regulatory application seeking approval for the combination regimen, ublituximab plus Ukoniq. It also withdraws Ukoniq from sale in approved indications.

TGTX : 5.44 (+0.93%)
VYGR : 6.13 (-3.62%)
TRVI : 2.25 (unch)
AXLA : 1.7300 (-0.57%)
TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL

Company voluntarily withdraws UKONIQ® from sale for approved indications of relapsed/refractory MZL and FL Company to host conference call, Monday, April...

TGTX : 5.44 (+0.93%)
TG Therapeutics Announces Oral Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at the American Academy of Neurology Annual Meeting

NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that data from the ULTIMATE I & II Phase 3 trials...

TGTX : 5.44 (+0.93%)
TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis Presented at the American Academy of Neurology Annual Meeting

NEW YORK, April 04, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced data from the ULTIMATE I & II Phase 3 trials...

TGTX : 5.44 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various...

See More

Key Turning Points

3rd Resistance Point 5.91
2nd Resistance Point 5.75
1st Resistance Point 5.59
Last Price 5.44
1st Support Level 5.27
2nd Support Level 5.11
3rd Support Level 4.95

See More

52-Week High 41.00
Fibonacci 61.8% 27.18
Fibonacci 50% 22.91
Fibonacci 38.2% 18.63
Last Price 5.44
52-Week Low 4.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar